Sino Biopharmaceutical | 1177 - Cost Of Sales

Stock Price
5.17
Daily Change
-0.07 -1.34%
Monthly
-11.17%
Yearly
23.39%
Q2 Forecast
5.22

Sino Biopharmaceutical reported CNY3.08B in Cost of Sales for its fiscal semester ending in June of 2025.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.3M 166K Dec/2025
Cspc Pharmaceutical CNY 2.11B 173.58M Dec/2025
Ionis Pharmaceuticals USD 3M 5M Mar/2026
IQVIA Holdings USD 3.08B 161M Mar/2026
Jiangsu Hengrui CNY 1.09B 76.27M Mar/2026
Moderna USD 955M 503M Mar/2026
Organon & Co USD 766M 21M Dec/2025
Revvity USD 323.46M 26.93M Mar/2026
Sino Biopharmaceutical CNY 3.08B 589.65M Jun/2025
Viatris USD 2.36B 195.9M Mar/2026
Xeris Pharmaceuticals USD 13.66M 49K Dec/2025